1. Home
  2. PICS vs VOR Comparison

PICS vs VOR Comparison

Compare PICS & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PicS N.V. Class A Common Shares

PICS

PicS N.V. Class A Common Shares

HOLD

Current Price

$9.29

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

HOLD

Current Price

$21.35

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PICS
VOR
Founded
2012
2015
Country
Brazil
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
PICS
VOR
Price
$9.29
$21.35
Analyst Decision
Strong Buy
Buy
Analyst Count
6
10
Target Price
$22.00
$45.33
AVG Volume (30 Days)
545.1K
725.4K
Earning Date
05-30-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$33.65
N/A
Revenue Next Year
$39.85
N/A
P/E Ratio
$29.44
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.32
$6.50
52 Week High
$18.49
$49.95

Technical Indicators

Market Signals
Indicator
PICS
VOR
Relative Strength Index (RSI) 35.95 41.97
Support Level $8.32 $11.62
Resistance Level $11.48 $22.22
Average True Range (ATR) 0.68 1.17
MACD -0.12 -0.38
Stochastic Oscillator 1.07 0.42

Price Performance

Historical Comparison
PICS
VOR

About PICS PicS N.V. Class A Common Shares

PicS NV is a digital payments company. The company operates a peer-to-peer (P2P) transfer platform that enables individuals to send money via mobile devices. It provides digital wallets, instant payments (Pix), P2P transfers, credit cards, loans, investments, insurance, and SMB payment solutions. The company has four reportable segments: Consumer Banking, Small and Medium-Sized Businesses, Audiences and Ecosystem Integration, and Institutional. The majority of the company's revenue is derived from the Consumer Banking segment, which generates revenue from various transaction activities occurring in the digital wallet, such as Pix, peer-to-peer (P2P) transfers, and bill payments.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Share on Social Networks: